Quarterly Results

SHARBON BIO

NSE : NABSE : 590034ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE255.000 (0 %)
PREV CLOSE ( ) 255.00
OPEN PRICE ( ) 263.90
BID PRICE (QTY) 258.00 (25)
OFFER PRICE (QTY) 260.00 (58)
VOLUME 1120
TODAY'S LOW / HIGH ( )255.00 263.90
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Jun 2007
Mar 2007
Dec 2006
Sep 2006
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
645.73
401.93
352.48
316.97
Total Expenditure
556.86
339.88
296.11
265.74
PBIDT (Excl OI)
88.87
62.05
56.37
51.23
Other Income
2.51
1.64
0.54
0.33
Operating Profit
91.37
63.7
56.91
51.56
Interest
10.28
4.54
4.5
1.6
Exceptional Items
NA
NA
NA
NA
PBDT
81.09
59.16
52.41
49.96
Depreciation
7.56
3.14
3.03
1.47
Profit Before Tax
73.54
56.02
49.38
48.49
Tax
16.02
18.35
11.93
13.15
Provisions and contingencies
0.00
0.00
NA
NA
Profit After Tax
57.52
37.67
37.45
35.34
Extraordinary Items
0.00
0.00
NA
NA
Prior Period Expenses
0.00
0.00
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
57.52
37.67
37.45
35.34
Equity Capital
101.82
100.32
100.32
100.32
Face Value (IN RS)
10
10
10
10
Reserves
0
0
Calculated EPS
5.64
3.75
3.73
3.52
Calculated EPS (Annualised)
22.59
15.01
14.93
14.09
No of Public Share Holdings
3769325
3619325
3619325
3619325
% of Public Share Holdings
37.02
36.08
36.08
36.08
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
13.76
15.43
15.99
16.16
PBIDTM%
14.15
15.84
16.14
16.26
PBDTM%
12.55
14.71
14.86
15.76
PBTM%
11.38
13.93
14.00
15.29
PATM%
8.90
9.37
10.62
11.14
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.